Available As Chewable Flavored Tablet
Specification 5mg/tablet * 30 tablets/box; 25mg/tablet * 30 tablets/box
Product Advantage:
1) Ultrafine crushing technology for enhanced absorption efficiency
Enroserene employs ultrafine crushing technology to process raw pharmaceutical materials into superfine powder with a particle size of 1μm—significantly smaller than the 45μm particle size of commercially available Enrofloxacin—ensuring more thorough absorption.
① Accelerated oral absorption efficiency: Rapid absorption within 15 minutes post-administration, achieving peak plasma concentration within 1 hour for swift therapeutic effect.
② Improved bioavailability: Bioavailability reaches 91.8%, surpassing that of comparable market products (72%~80%).
2) Coating-like tableting process, diverse administration methods
Enroserene employs a coating-like tableting process that effectively mitigates the impact of external environmental factors—such as light, humidity, and temperature—on drug absorption. Enroserene supports multiple administration methods including direct feeding,powder mixing, and administration via drinking water,with no compromise to pharmaceutical efficacy.
3) Cross-shaped score line,facilitates accurate splitting
Enroserene features a cross-shaped score line for precise tablet division, enabling precise dosing for smaller animals and streamlining medication administration.
4) Broad-spectrum antibacterial activity with High efficacy against Mycoplasma
Enroserene demonstrates exceptional efficacy against Mycoplasma, while also exhibiting potent bactericidal effects against a wide range of pathogens, including:Escherichia coli, Klebsiella spp., Salmonella spp., Proteus spp., Pseudomonas aeruginosa, Haemophilus spp., Pasteurella multocida, Mannheimia haemolytica, Staphylococcus aureus, Streptococcus spp.,also exhibits bactericidal effects against Gram-negative bacteria.
Indication:
1) Upper respiratory infections in dogs and cats: acute inflammations of the nasal cavity, pharynx, and larynx, etc.
2) Lower respiratory infections in dogs and cats: acute/chronic bronchitis, pneumonia, pleural empyema (pyothorax), etc.
3) Digestive system infections in dogs and cats: bacterial enteritis/colitis, cholecystitis, suppurative cholangiohepatitis, etc.
4) Urogenital infections in dogs and cats: urinary tract infections (utis), mastitis, pyometra, etc.
5) Infections in exotic pets: bacterial infections in birds, ferrets, reptiles, rodents, rabbits, etc.
